Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: A retrospective cohort study

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 7, 2006, Pages 818-822

  Vignes, Stephane ^a   Dupuy, A ^b  

^a Hopital de la Fondation Cognacq Jay   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Breast cancer; Lymphoedema; Risk factor; Secondary

Indexed keywords

ANTIBIOTIC AGENT; ANTIESTROGEN; ANTINEOPLASTIC AGENT; BENZATHINE PENICILLIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARM DISEASE; ARTICLE; BODY MASS; BREAST CANCER; CANCER HORMONE THERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYSIPELAS; FEMALE; FOLLOW UP; HUMAN; LYMPHEDEMA; MEDICAL DOCUMENTATION; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARM; BREAST NEOPLASMS; ERYSIPELAS; FEMALE; HUMANS; LYMPHEDEMA; MIDDLE AGED; PENICILLIN G BENZATHINE; PENICILLIN G, BENZATHINE; RECURRENCE;

EID: 33746310330     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01648.x     Document Type: Article

References (23)

1. Harris SR, Hugi MR, Olivotto IA, Levine M; Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 2001; 164: 191-199.
2. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-1377.
3. Wang JH, Liu YC, Cheng DL et al. Role of benzathin penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis 1997; 25: 685-689.
4. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 2003; 36: 84-91.
5. Lennihan R Jr, Mackereth M. Calculating volume changes in a swollen extremity from surface measurements. Am J Surg 1973; 126: 649-652.
6. Megens AM, Harris SR, Kim-Sing C, McKenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil 2001; 82: 1639-1644.
7. Galland C, Auvert JF, Flahault A, Vayssairat M. Why and how post-mastectomy edema should be quantified in patients with breast cancer. Breast Cancer Res Treat 2002; 75: 87-89.
8. Ferrieri P, Dajani AS, Wannamaker LW. Benzathine penicillin in the prophylaxis of streptococcal skin infections: A pilot study. J Pediatr 1973; 83: 572-577.
9. Bitnun S. Prophylactic antibiotics in recurrent erysipelas. Lancet 1985; 1: 345.
10. Duvanel T, Harms M, Merot Y, Saurat JH. Evaluation of prophylactic benzathin-penicillin in the prevention of recurrent erysipelas. Dermatologica 1986; 173: 205-208.
11. Dankert J, Bouma J. Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy. Br J Obstet Gynaecol 1987; 94: 788-790.
12. Kremer M, Zuckerman R, Avraham Z, Raz R. Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 1991; 22: 37-40.
13. Sjöblom AC, Ericksson B, Jorup-Rönström C et al. Antibiotic prophylactic in recurrent erysipelas. Infection 1993; 21: 390-393.
14. Chakroun M, Ben Romdhane F, Battikh R et al. Benzathine penicillin prophylaxis in recurrent erysipelas. Med Mal Infect 1994; 24: 894-897.
15. Shenoy RK, Kumaraswami V, Suma TK et al. A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 1999; 93: 367-377.
16. Olszewski WL. Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathin penicillin: A preliminary study. Lymphology 1996; 29: 126-131.
17. Dupuy A, Benchikhi H, Roujeau JC et al. Risk factors for erysipelas of the leg (cellulitis): Case-control study. BMJ 1999; 318: 1591-1594.
18. Vijayalakshmi N, Sambasiva Rao R, Anand Kumar MP et al. Role of aerobic bacteria in the aetio-pathogenesis of acute adenolymphangitis (ADL) in filarial lymphoedema. Lymphology 2000; 33: 163.
19. Vaqas B, Ryan TJ. Lymphoedema: Pathophysiology and management in resource-poor settings: Relevance for lymphatic filariasis control programmes. Filaria J 2003; 2: 4.
20. Mallon E, Powell S, Mortimer P, Ryan TJ. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997; 137: 928-933.
21. Sachs MK. Cutaneous cellulitis. Arch Dermatol 1991; 127: 493-496.
22. Badger C, Seers K, Preston N, Mortimer P. Antibiotics/ anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbs. Cochrane Database Syst Rev 2004; 2: CD003143.
23. Currie BJ, Burt T, Kaplan EL. Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Antimicrob Agents Chemother 1994; 38: 1203-1204.